Karen Alexander
Chief Financial Officer, BACT
Replay available
Bakkt Holdings, Inc. (NYSE: BKKT) Q1 2025 earnings conference call, held 2025-05-12. Replay captured from the company's public earnings webcast.

Chief Financial Officer, BACT
Investor Relations Advisor, BACT
Founder of Distributed Technologies Research & Co-CEO, BACT
Greetings and welcome to the BACT first quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. As a reminder, this conference call is being recorded. I'll now turn it over to Cody Fletcher, investor relations advisor at BACT. Please go ahead. Hello, everyone, and thank you for joining BACT's first quarter 2025 earnings call. Before we get started, I'd like to remind everyone that today's earnings call includes a separate supplemental presentation that can be found at our investor relations website at www.investors.bact.com. During today's call, we will make certain forward-looking statements, including statements regarding our cooperation agreement with DTR, the proposed commercial agreement with DTR expected by Q3 2025, and the anticipated integration of DTR stablecoin and AI payment infrastructure with BAC's regulated platform. We'll also discuss our strategic transformation to a pure play crypto infrastructure company, including the divestiture of our custody business to ICE, including expected timelines and ongoing discussions regarding our loyalty business, as well as expectations regarding the stablecoin payments market, regulatory environment, and our product roadmap. These statements are based on management's current expectations and are subject to risks and uncertainties. which may cause actual results to differ materially from those expressed or implied in such forward-looking statements. For additional information regarding forward-looking statements and risk factors, please refer to our filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the first quarter of 2025. Further, in addition to discussing results that are calculated in accordance with generally accepted ac...